Main Laboratory Measurements (Range) in Patients With MGUS and AvWS
| Laboratory Measurements . | IgG-MGUS (n = 8) . | IgM-MGUS (n = 2) . | Normal Controls (n = 20) . |
|---|---|---|---|
| BT (min) | 10-21 | 18-23 | 3-7 |
| Factor VIII:C (U/dL) | 9-36 | 20-36 | 62-156 |
| vWF:Ag (U/dL) | 3-16 | 26-37 | 52-148 |
| vWF:RCo (U/dL) | <6 | <6 | 49-151 |
| vWF:propeptide (U/dL) | 54-216 | 49-53 | 49-158 |
| vWF (propeptide/Ag) ratio | 7-51 | 1.3-2 | 0.7-1.9 |
| High molecular weight multimers | |||
| in plasma | Present | Absent | Present |
| in platelets | Present | Present | Present |
| Laboratory Measurements . | IgG-MGUS (n = 8) . | IgM-MGUS (n = 2) . | Normal Controls (n = 20) . |
|---|---|---|---|
| BT (min) | 10-21 | 18-23 | 3-7 |
| Factor VIII:C (U/dL) | 9-36 | 20-36 | 62-156 |
| vWF:Ag (U/dL) | 3-16 | 26-37 | 52-148 |
| vWF:RCo (U/dL) | <6 | <6 | 49-151 |
| vWF:propeptide (U/dL) | 54-216 | 49-53 | 49-158 |
| vWF (propeptide/Ag) ratio | 7-51 | 1.3-2 | 0.7-1.9 |
| High molecular weight multimers | |||
| in plasma | Present | Absent | Present |
| in platelets | Present | Present | Present |